Atul Deodhar, M.D., is quoted in a talk he delivered at a conference about developing treatments for axial spondyloarthritis. He says, “Classification is very important for enrolling patients into clinical trials. Non classification criteria were used because none are available – none exist.”

Roger Dailey, M.D., F.A.C.S., is quoted in a Business Wire news release in which Horizon Therapeutics announced findings of a real-world adherence analysis of the first and only FDA-approved medicine to treat thyroid eye disease, a serious and progressive rare autoimmune disease.

OHSU is partnering with the University of Cape Town’s Institute of Infectious Disease and Molecular Medicine through an NIH-funded program to train research graduate students and faculty from participating African institutions.

A safety analysis by The Leapfrog Group scores OHSU Hospital and OHSU Health Hillsboro Medical Center with C grades.

OHSU is among five hospitals nationwide selected as recipients for the American Academy of Pediatrics’ Community Partnership Approaches for Safe Sleep.

New bills slated to bolster children’s mental health services, including comments from Ajit Jetmalani, M.D., who says, “We saw a massive loss of workforce in the children’s health system. And what’s happened now is that people are not coming back.”

In a story highlighting the need for clear metrics to ease public health measures like mandatory outdoor masking, The Oregonian cites OHSU research noting that hospitalizations aren’t projected to recede to pre-delta levels until around February.

In news coverage of OHSU’s Nov. 11 statewide forecast, Peter Graven, Ph.D., says, “There are more and more infections occurring, and immunity is building up. As that happens, it becomes harder and harder to generate a surge in hospitalizations.”

Common sense measures to protect eyesight as people age. Merina Thomas, M.D., says, “If you have a family history of eye disease, especially glaucoma or [macular degeneration], you should get an eye exam once a year.”

Tamara Ostervoss, director of OHSU’s Body Donation Program, writes that unethical use of whole-body donors by disreputable body donation programs undermines public trust and impacts health care education. She writes, “I want to be clear that OHSU treats donors with the utmost of respect and care.” Full viewpoint posted on OHSU News, with shorter version published as a letter to the editor in The Oregonian